Tag Archives: Agri & Food

Altamir to invest via the Apax France IX fund in the Italian company AEB Group

Altamir

AEB Group, a worldwide leader in biotechnological ingredients for wine, food and beverage.

Paris, 21 September 2018 – As announced in our press release dated 5 September, a new transaction has been signed by Apax Partners SAS: the acquisition from SK Capital of 100% of the Italian company AEB Group, a worldwide leader in biotechnological ingredients and related services for wine, food and beverage. The company’s management will reinvest alongside Apax Funds.

Leveraging their expertise in biotechnology and oenology, AEB Group offers custom solutions based on more than 600 proprietary products and specialty equipment, especially designed for the wine, beer, juice, cider and food industry.

With a unique coverage across 5 continents, AEB Group employs more than 300 persons, including 170 agents and sales representatives in 13 countries. The company has 8 production units, 4 R&D laboratories and 7 quality control laboratories globally and collaborates with more than 20 universities and research institutes to foster continuous innovation. In 2017, the company generated revenues of nearly €100 million.

The company’s objective is to pursue its international expansion by leveraging the existing worldwide sales and agents network and to conduct an ambitious buy and build strategy.

Financial terms of the transaction are not disclosed. Closing of the transaction is expected in the beginning of October.

Altamir’s investment is expected to be in the region of €35m based on the upper limit of its commitment in the Apax France IX fund.

About Altamir

Altamir is a listed private equity company (Euronext Paris-B, ticker: LTA) founded in 1995 and with almost €800m in assets under management. Its objective is to provide shareholders with long term capital appreciation and regular dividends by investing in a diversified portfolio of private equity investments.

Altamir’s investment policy is to invest via and with the funds managed by Apax Partners SAS and Apax Partners LLP, two leading private equity firms that take majority or lead positions in buyouts and growth capital transactions and seek ambitious value creation objectives.

In this way, Altamir provides access to a diversified portfolio of fast-growing companies across Apax’s sectors of specialisation (TMT, Consumer, Healthcare, Services) and in complementary market segments (mid-sized companies in French-speaking European countries and larger companies across Europe, North America and key emerging markets).

Altamir derives certain tax benefits from its status as an SCR (“Société de Capital Risque”). As such, Altamir is exempt from corporate tax and the company’s investors may benefit from tax exemptions, subject to specific holding-period and dividend-reinvestment conditions.

For more information: www.altamir.fr

Contact

Agathe Heinrich

Tel: +33 1 53 65 01 74

E-mail: investors@altamir.fr

Categories: News

Tags:

Scanship signs contract with Atlantic Sapphire

 

Reiten

Scanship has signed a contract with Billund Aquakulturservice for the delivery of a sludge handling system to Atlantic Sapphire – the world’s largest onshore salmon fishfarm based in Miami. Atlantic Sapphire’s facility will be built in several steps and the Scanship contract includes supplying its “environmental protection and circular economy” technology for the first step.

Atlantic Sapphire’s facility will be the worlds largest with an annual production capacity of 90.000 tonn when completed.

“With this milestone contract, we are now in all three segments of a growing aquaculture market for smolt, seabased closed cage and landbased farms”, says CEO in Scanship Henrik Badin.

Categories: News

Tags:

TowerBrook signs definitive agreement for sale of Wilton Brands

New York – September 10, 2018 – TowerBrook Capital Partners L.P. (“TowerBrook”), an international investment management firm, today announced the sale of Wilton Brands, a baking, cake decorating and candy making brand, to Dr. August Oetker KG (“Dr. Oetker”). Financial terms were not disclosed, and the transaction is expected to close by the end of the year.

Dr. Oetker is a Germany based, privately held, global food and beverage company, which includes baking products and baked goods. Both companies were family-founded and share a long and rich heritage in baking.

The sale to Dr. Oetker positions Wilton Brands to draw on both companies’ strengths and combined knowledge as the business continues to grow and innovate for the benefit of customers, retail partners and employees. Wilton’s product portfolio and strong brand makes it a compelling fit for Dr. Oetker as the company accelerates its expansion in the U.S.

Since TowerBrook acquired Wilton Brands in 2009, the company re-focused on its baking and food core while successfully divesting non-core businesses. Wilton products can be found on shelves at Walmart, Target, Michael’s, Kroger and grocers across the U.S., as well as on Amazon, and are distributed through partners on every continent.

Wilton Brands will remain headquartered in Naperville, Illinois and will be run as a division within the broad portfolio of companies owned by Dr. Oetker. Sue Buchta will remain in her role as CEO of Wilton Brands.

Categories: News

Tags:

HENDRIX GENETICS ramps up investment in US| NPM CAPITAL

No Comments

NPM Capital

Hendrix Genetics has substantially expanded and upgraded its US facilities, including its turkey hatcheries and prawn and trout farms. These investments will help the global leader in animal genetics to significantly strengthen its position in the US market.

Highest-quality turkeys

The company has invested tens of millions of dollars in the construction of two new hatcheries and various new egg production facilities. In addition, Hendrix Genetics has purchased new state-of-the-art trucks equipped with hatching facilities and established a modern distribution network to increase the number of turkey deliveries in the United States and beyond. Through these investments, the NPM Capital portfolio company guarantees a reliable supply of the highest-quality products.

Hendrix Genetics opened the first state-of-the-art hatchery in Grand Island, Nebraska in late 2017, with a capacity of 100,000 one-day old chicks a day, five days a week. This investment comes in the wake of a major upgrade carried out at the grandparent stock facility in Virginia.

The new barns were built in accordance with Hendrix Genetics’ stringent guidelines, to ensure that its high quality standards are complied with across the entire supply chain.

Increased prawn exports

Since partnering with Hawaiian-based Kona Bay Marine Resources in 2017, Hendrix Genetics also supplies prawns. A brand-new packaging and shipping facility recently became operational on the premises of the hatchery on the island of Kauai. The investment will help to boost prawn exports, while maintaining the current high quality levels.

Top-quality trout

The trout farm operated by Hendrix Genetics in Washington State has been a global supplier of the finest trout for more than 70 years. These high quality levels are also guaranteed through investments in research capacity and a major extension of the Family Genetics building. The company’s incubator is currently one of the largest privately-owned facilities of its kind worldwide.

Categories: News

Tags:

Kinnevik invests in Kolonial.no – the leading online grocery store in Norway

Kinnevik

Kinnevik AB (publ) (“Kinnevik”) today announced that it has invested NOK 300m in Kolonial.no AS for a 15% stake in the Norwegian online grocery retailer.

Kinnevik invested NOK 200m in primary capital and a further NOK 100m in secondary shares. Kolonial.no was founded in 2013 and offers grocery delivery to approximately 40% of Norwegian households, a share that they expect to expand over time. The company grew revenues by 88% to approximately NOK 800m in 2017.

Andreas Bernström, Kinnevik Investment Director, commented:

“We are excited to lead the funding round in Kolonial.no, a company that fits squarely into our investment thesis of using technology to offer consumers more and better choice. We have been impressed by the founding team and what they have achieved in a relatively short period of time. Kinnevik is well placed to support the team in scaling the business and we look forward to working with Kolonial.no to reach their goals.”

Karl Munthe-Kaas, CEO Kolonial.no commented:

“Kinnevik is a dream partner for us. We feel there is a great fit in both the strategic vision and the values of our companies. Our ambition is to make grocery shopping an effortless and inspiring activity for everyone and bring freedom in their everyday lives. Kinnevik has the right expertise and the right mindset to help us in this journey and we are very excited to work with them.”

For further information, visit www.kinnevik.com or contact:

Torun Litzén, Director Investor Relations
Phone +46 (0)70 762 00 50
Email press@kinnevik.com

Kinnevik is an industry focused investment company with an entrepreneurial spirit. Our purpose is to build digital businesses that provide more and better choice. We do this by working in partnership with talented founders and management teams to create, develop and invest in fast growing businesses in developed and emerging markets. We believe in delivering both shareholder and social value by building companies that contribute positively to society. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.

Categories: News

Tags:

Ploeger Oxbo strengthens shareholder base through investment NPM Capital

NPM Capital

Ploeger Oxbo Group has attracted a new major shareholder. NPM Capital is the strong financial partner that the manufacturer of specialty agricultural equipment has been looking for to support its long-term growth strategy. This strategy is aimed at bolstering innovation and product development to further strengthen Ploeger Oxbo’s leading position in its worldwide niche markets. The transaction file has also been submitted to the required Competition Authorities.

Ploeger Oxbo’s roots go back to the 1950’s. The group was formed in 2011 in a merger between Netherlands-based Ploeger and US-based Oxbo. Over the past decades, the companies have expanded rapidly as a result of autonomous growth and acquisitions. From a strong position in harvesters for corn, beans and peas the product range has been expanded to equipment for crops like potatoes, berries, coffee, olives and grapes and to self-propelled windrow mergers, sprayers and fertilizer applicators. Ploeger Oxbo has a leading position in these niche markets and operates in forty countries on all continents. Over the past months both Ploeger Oxbo and NPM Capital have developed a shared vision on the strategic direction of the company.

“This company has a strong entrepreneurial spirit”, say Gary Stich and Niels Havermans, both Board members at Ploeger Oxbo. “The fact that the founders of the group in 2011, both private as well as three Dutch investment companies (Synergia Capital Partners, VDL Participatie and via Bolster Investment Partners), will participate in the future shows a great level of confidence in the markets we are in as well as the strategic direction of the company. Together we have decided to sell 40 percent of our holdings to a powerful financial partner who shares our values and focus on long-term development and can support add-on acquisitions.”

The participation in Ploeger Oxbo Group fits NPM Capital’s focus on the agri-tech sector, says Rutger Ruigrok, managing partner of the investment company. “Ploeger Oxbo creates innovative solutions for the agricultural sector that needs new technologies to be able to feed a fast-growing world population. It is a company with both great social value and strong growth potential – exactly what we are looking for.”

Ploeger Oxbo was advised by Nielen Schuman (financial) and DLA Piper (legal). NPM Capital was advised by Rabobank and Vondel Finance (financial) and Nauta Dutilh (legal).

Categories: News

Tags:

The Carlyle Group completes acquisition of Tessara

No Comments

Carlyle

The Carlyle Group completes acquisition of Tessara, a South African manufacturer of fresh produce preservation solutions

Cape Town, South Africa, 1 August 2018 – Global alternative asset manager The Carlyle Group (NASDAQ: CG) today announced it has completed the acquisition of a majority stake in Tessara, a manufacturer of preservation technologies for use in the marketing and export of fresh produce.

The transaction closed on 31 July 2018 and funding for this investment came from Carlyle Sub-Saharan Africa Fund. Financial terms are not disclosed.

Founded in 1985, Tessara is a well-established business with a strong brand and a growing global market position in Sulfur Dioxide (SO2)-based sheets for use in the preservation of fresh produce. Its flagship product is Uvasys, a SO2-based sheet, primarily used to protect table grapes against Botrytis infection, which is responsible for almost 50% of all post-harvest agricultural loss. Uvasys also enhances transportation, export and storage of grapes. Tessara has rapidly grown its business both in South Africa and internationally with exports now representing more than 65% of annual sales.

Tessara employs more than 150 people and has manufacturing facilities in Cape Town, South Africa. The company operates through a network of 15 distributors and it has built strong relationships with both suppliers and customers.

Bruce Steen, Principal in Carlyle’s Sub-Saharan Africa Fund, said: “Tessara is a great business with exciting growth prospects. Led by an experienced, talented management team, Tessara has built an impressive reputation for its core product whilst investing in R&D and the opportunity that exists to expand the product pipeline and broaden the application of SO2 sheets. We look forward to partnering with Tessara at this exciting time, supporting their continued growth and innovation and fueling expansion into new products and markets, especially China and USA.”

Craig Cloete, CEO of Tessara, said: “We are delighted to partner with Carlyle as we embark on a new chapter of development. We believe Carlyle’s global network, scale and experience, supporting international growth, will help us boost our sales and expand into new markets.”

Carlyle was advised on the transaction by Webber Wentzel and Ernst & Young.

*****

About Tessara

Tessara is the global market leader in the supply of laminated SO2 generator sheets to protect table grapes from post-harvest decay and prevent Botrytis infection during transportation and storage.

The company was founded in South Africa in 1985 and today it employs over 150 people.

About The Carlyle Group

The Carlyle Group (NASDAQ: CG) is a global alternative asset manager with $201 billion of assets under management across 324 investment vehicles as of March 31, 2018. Carlyle’s purpose is to invest wisely and create value on behalf of its investors, many of whom are public pensions. Carlyle invests across four segments – Corporate Private Equity, Real Assets, Global Credit and Investment Solutions – in Africa, Asia, Australia, Europe, the Middle East, North America and South America. Carlyle has expertise in various industries, including: aerospace, defense & government services, consumer & retail, energy, financial services, healthcare, industrial, real estate, technology & business services, telecommunications & media and transportation. The Carlyle Group employs more than 1,575 people in 31 offices across six continents.

 

Web: www.carlyle.com
Videos: www.youtube.com/onecarlyle
Tweets: www.twitter.com/onecarlyle
Podcasts: www.carlyle.com/about-carlyle/market-commentary

About Carlyle Sub-Sahara Africa Fund (SSA)

Established in 2012 the Carlyle Sub-Saharan Africa Fund and its affiliates, with $698 million of committed capital, have invested over $450 million to date across a variety of industries, including energy, financial services, TMT, retail, logistics and mining services, and across a variety of geographies, including South Africa, Gabon, Nigeria, Mozambique, Zambia, Tanzania, and the Democratic Republic of the Congo. The SSA fund makes buyout and growth capital investments in private and public companies from offices in Johannesburg, South Africa and Lagos, Nigeria.

Media Contact:

Katarina Sallerfors
Katarina.sallerfors@carlyle.com
+44 (0)20 7894 3554

Categories: News

Tags:

Bergfalk & Co and Johan i Hallen form a leading specialist in fresh food products in Sweden

Litorina

Through a partnership between Bergfalk & Co and Johan i Hallen one of the leading specialists with focus on meat, delicatessen meat, fish and seafood is formed. The new group will have a strong market position in Stockholm and Gothenburg with good coverage in the rest of the country and a turnover of approximately SEK 1.2 billion. Johan i Hallen’s former major shareholders and senior management remain as significant shareholders in the new group along with former major shareholders and senior management of Bergfalk & Co and Litorina.

Earlier this year, Litorina acquired a majority in Bergfalk & Co together with the former major shareholders and senior management. In order to establish a more competitive participant in the market, a partnership with Johan i Hallen has been formed.

Johan i Hallen was founded in 1916 and has since then grown its revenues to approximately SEK 640 million. The company has a significant market position in Sweden, with clear history from Gothenburg. Johan i Hallen offers high quality fresh foods with focus on meat and delicatessen meat, primarily to restaurants and hotels which account for most of the turnover. The company has built its strong market position and well-reputed, brand by offering competence, product quality and own production combined with a local presence, speed, flexibility and a high level of service.

“We have a vision to become the Nordic region’s best protein specialist, and to us, this deal feels very exciting. The fit between Bergfalk & Co and Johan i Hallen is very good, as Bergfalk & Co primarily has its focus in Stockholm, while Johan i Hallen is strong in western Sweden albeit with a nationwide profile. Together, we obtain a broader and more powerful customer offering and the new group will be the natural choice for professional restaurant owners and chefs concerning the protein in the middle of the plate,” says Lars Bengtsson, CEO of Bergfalk.

“By means of the partnership between Bergfalk & Co and Johan i Hallen, a leading specialist in the distribution of meat and fish to restaurants is formed. There are extensive similarities in how Bergfalk & Co and Johan i Hallen work with their customers, and via this deal together we can establish an even stronger customer offering” says Johan Andersson, Partner in Johan i Hallen.

“We are exceptionally enthusiastic about the formation of this group and believe that this transaction has a clear industrial logic. Bergfalk & Co and Johan i Hallen complement each other in terms of customers, geographical presence and product lines. In addition, the companies have strong similarities in the way they work with their customers. We look forward to supporting the new group and its key people on the path to further development and growth,” says Lars Verneholt, Partner at Litorina V Advisor AB, Investment Advisor to Litorina V AB.

For further information, please contact:
Lars Verneholt, +46 73 386 92 07, Partner, Litorina V Advisor AB
Lars Bengtsson, +46 70 523 30 02, CEO, Bergfalk & Co
Per Erik Engström, +46 70 752 55 83, CEO, Johan i Hallen
Johan Andersson +46 70 884 44 04, Partner, Johan i Hallen

 

Bergfalk & Co was founded in 1840 and is a leading Swedish specialist in fresh products with a focus on meat, fish and seafood. The company offers high quality products, primarily to restaurants in Sweden and Finland. as well as to the grocery trade. Bergfalk has an annual turnover of approx. SEK 550 million, and has over 140 employees, with headquarters in Älvsjö, just outside Stockholm. For more information, please visit www.bergfalk.se.

Johan i Hallen was founded in 1916 and is a leading Swedish specialist in fresh products with a focus on fresh meat and processed meats. The company offers high quality products primarily for restaurants and hotels in Sweden. Johan i Hallen has an annual turnover of approx. 640 million, and has over 125 employees, with headquarters in Partille, near Gothenburg. For more information, please visit www.johanihallen.se.

Litorina was founded in 1998 and focuses on acquiring and industrially developing primarily Swedish companies together with their management teams. Litorina offers broad and deep expertise via both its own organisation and through its network of industrial advisors. Litorina V Advisor AB acts as an investment advisor to the Swedish private equity fund Litorina V AB. For more information, please visit www.litorina.se.

Categories: News

Tags:

AURELIUS subsidiary Conaxess Trade partners with Spreads

Aurelius Capital

  • Partnership with former Unilever BCS business to start August 1, 201
  • Conaxess to take over Field Sales activities in three Nordic coutries

June 11, 2018 – Conaxess Trade is happy to officially announce a partnership with the new stand-alone Spreads business (formerly Unilever BCS) beginning August 1, 2018 where Conaxess Trade proudly will take responsibility for the Field Sales activities. The partnership applies to the three Nordic countries Denmark, Sweden and Finland. In the Nordic region the Spreads business includes the brands Flora, Becel, Milda, Lätta, Crème Bonjour, Crème Fine and Oma. In total the consumer sales of the brands is app. EUR 220mn.

The background is that Unilever in December 2017 received a binding offer for the Spreads business (includes *BCS Europe and North America, Rest of World Spreads and UFS Spreads) from leading global investment firm KKR. The transfer will take place gradually and the first stage is planned from Q3 2018 – when the Spreads business will begin operating as a stand-alone organization.

Conaxess Trade will be significantly increasing their muscles in the market, providing best in class FMCG services by further strengthening the sales force coverage, and not to mention the higher relevance and access to consumers.

Uwe Thellmann, CEO Conaxess Trade Group comments: “Today’s announcement is another important step in our journey to build on our foundation in Fast Moving Consumer Goods and become the leader in outsourcing for Marketing and Sales Services. This cooperation will help us to fully deliver on our “Outsourcing Partner Strategy” by giving us strong capabilities and business foundation to further develop in the Nordics. The relationship with the former Unilever BCS portfolio represents a powerful opportunity for Conaxess Trade to expand our services and build stronger relationships with our customers”.

Ola Pettersson, Interim General Manager Unilever BCS Sverige AB comments: “We have a strong commitment to grow our plant based food category and believe Conaxess Trade with their set-up, coverage of the trade and capabilities will be a great partner for delivering Field Sales in Sweden, Finland and Denmark. This is an important step in building a best-in-class route to market for our new Company. We believe that we together will sustain the high standards set by Unilever and further develop our business.

“Conaxess Trade has significantly changed over time and is developing from a traditional distributor to become a vibrant leading FMCG Outsourcing Company with best in class services in Marketing, Category Management, Sales, Reporting, Business Development. It clearly demonstrates its ability to apply its resources and expertise not only to enter new businesses, but to lead major FMCG market segments. We’re excited to cooperate with the stand-alone Spreads business as we focus our combined energies serving our customers and developing the business”, says Uwe Thellmann, CEO Conaxess Trade Group.

Categories: News

Tags:

Nordic Capital divests AniCura, a leading European provider of vet care, to Mars Petcare in one of the largest transactions in its sector

Nordic Capital

June 11 2018
Nordic Capital divests AniCura, a leading European provider of vet care, to Mars Petcare in one of the largest transactions in its sector Image 

  • AniCura has grown fourfold during Nordic Capital’s four year ownership, shaping the European vet care market
  • The sale of AniCura to Mars Petcare represents one of the largest vet care deals globally
  • Natural next step in AniCura’s mission to increase the quality of specialised and advanced vet care in Europe

 

Nordic Capital Fund VIII has agreed to divest AniCura, one of Europe’s leading providers of high quality veterinary care for companion animals to Mars Petcare, a diverse and growing pet health and nutrition business. Since becoming the majority owner just four years ago, Nordic Capital and AniCura’s management team have succeeded in shaping the European vet care landscape by creating a specialised clinic business with high quality pet care at its heart.

Mars Petcare is ideally placed to support AniCura’s continued journey as a leading provider of high quality specialised and advanced vet care in Europe and the deal marks one of the best ever exits for Nordic Capital, a leading investor in global healthcare, which closed its ninth fund at EUR 4.3 bn last month.

Born out of the premise that sharing resources creates opportunities for better veterinary care, AniCura was established in 2011 by Fidelio Capital and The Animal Hospital Foundation in Greater Stockholm as the first merger of companion animal hospitals in the Nordic region. Nordic Capital became the majority owner in 2014 alongside the previous owners. With Nordic Capital’s support and extensive experience from a 25-year track record of building high quality, sustainable healthcare businesses across Europe and the USA, AniCura has developed from a Nordic vet care operator to become a pan-European leader in its space. This was achieved through a dedicated focus on providing the highest quality of care and an active acquisition strategy that has expanded AniCura’s presence across Northern Europe, with 150 clinics acquired in three years. Simultaneously, significant investments have been made in the company to meet future veterinary healthcare needs, improving and professionalising veterinary medical care.

AniCura has grown fourfold since Nordic Capital’s acquisition in 2014. It has increased its number of clinics from 50 to 200, its employees from 1,000 to 4,000 people and its pro forma revenues have grown from approx. SEK 0.9 bn to SEK 3.3 bn. Today, the company cares for 2 million companion animals per year (up from 500,000 in 2014), and AniCura is a valued partner for pet owners and referring veterinarians across Europe, including Scandinavia, Germany, Austria, Switzerland and the Netherlands.

AniCura offers a wide range of high quality medical services covering preventive and basic health care as well as advanced diagnostics, internal medicine, intensive care, surgery and orthopaedics. The company also provides rehabilitation, physiotherapy and dietary advice and offers selected pet food and care products.

“AniCura is an excellent example of entrepreneurial business innovation that puts compassion for patients and pet owners at its heart. AniCura is unique in Europe due to its strong and differentiated corporate culture focused on ensuring the highest possible care quality as well as nurturing a sense of teamwork. Together with Peter and his team, Nordic Capital has focused on building a strong pan-European network of clinics that offers consistently high standards of pet care and shares a commitment to best in class quality and service. AniCura has created a platform for further growth and is very well placed to meet the increasing demands that apply to the provision of advanced vet care,” says Thomas Vetander, Principal at the Advisor to the Nordic Capital Funds.

“We have thoroughly enjoyed partnering up with Nordic Capital to continue our relentless efforts on building an international champion, renowned for high quality standards, high levels of specialisation and a unique corporate culture. Nordic Capital’s supportive approach coupled with their deep insights in building industry leading healthcare businesses has ensured the right long-term focus on strategic growth and development. We are now taking the next step in our vision to shape the future of veterinary care. We believe this is the right next home for AniCura and look forward to a long and fruitful relationship with our new owner,” says Peter Dahlberg, CEO of AniCura.

“Mars Petcare has a long history of providing nutrition, veterinary care and science for pets across the globe. Our veterinary business until now has been in the United States and Canada. Europe is the second largest region in the world for pet care, and European pet care is expected to grow significantly over the coming years. There is a great opportunity to address growing demand by providing high quality, consistent veterinary care across Europe. Together, Mars Petcare and AniCura will both benefit from each other’s best practices and competencies, improving clinical practice and continuing to advance the veterinary profession in both North America and Europe. This will support us in our purpose to create a better world for pets,” says Poul Weihrauch, President, Mars Petcare.

The parties have agreed not to disclose financial details. The transaction is subject to customary regulatory approvals.

Media contact:

Nordic Capital
Katarina Janerud, Communications Manager
Advisor to the Nordic Capital Funds
Tel: +46 8 440 50 50
e-mail: katarina.janerud@nordiccapital.com

 

About Nordic Capital

Nordic Capital is a leading private equity investor in the Nordic region with a resolute commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. Nordic Capital focuses on selected regions and sectors where it has deep experience and a proven track record. Core sectors are Healthcare, Technology & Payments, Financial Services, Industrial Goods & Services and Consumer & Retail, and key regions are the Nordics, Northern Europe, and globally for Healthcare. Since inception in 1989, Nordic Capital has invested EUR 12 billion in 100 investments. The Nordic Capital Funds are based in Jersey and are advised by advisory entities, which are based in Sweden, Denmark, Finland, Norway, Germany and the UK. For further information about Nordic Capital, please visit www.nordiccapital.com  

About AniCura

AniCura is a family of well-known animal hospitals and clinics specialised in veterinary care for companion animals. Born out of the idea that sharing resources creates opportunities for better veterinary care, the company was established in 2011 by Fidelio Capital and The Animal Hospital Foundation in Greater Stockholm as the first merger of companion animal hospitals in the Nordic region. Today, AniCura is a role model within specialised veterinary care and a valued partner for pet owners and referring veterinarians across Europe. AniCura offers a wide range of high quality medical services covering preventive and basic health care as well as advanced diagnostics, internal medicine, intensive care, surgery and orthopaedics. AniCura also provides rehabilitation, physiotherapy and dietary advice and offers selected pet food and care products. AniCura provides modern, high-quality veterinary care for pets at 200 European locations and creates peace of mind for pet owners through excellent access and patient safety. Every year, AniCura’s 4,000 passionate veterinary professionals attend to more than two million companion animal patients. AniCura is a trusted training and referral body. For information on how AniCura is working to shape the future of veterinary care, please visit www.anicuragroup.com

About Mars Petcare

Mars Petcare is a diverse and growing business with 75,000 Associates across 50+ countries dedicated to one purpose: A BETTER WORLD FOR PETS. With 75 years of experience, our portfolio of almost 50 brands serves the health and nutrition needs of the world’s pets – including brands PEDIGREE®, WHISKAS®, ROYAL CANIN®, NUTRO™, GREENIES™, SHEBA®, CESAR®, IAMS™ and EUKANUBA™ as well as The WALTHAM Centre for Pet Nutrition which has advanced research in the nutrition and health of pets for over 50 years. Mars Petcare is also a leading veterinary health provider through a network of over 2,000 pet hospitals including BANFIELD™, BLUEPEARL™, PET PARTNERS™, and VCA™. We’re also active in innovation and technology for pets, with WISDOM PANEL™ genetic health screening and DNA testing for dogs, the WHISTLE™ GPS dog tracker, and LEAP VENTURE STUDIO accelerator and COMPANION FUND™ programs that drive innovation and disruption in the pet care industry. As a family business and guided by our principles, we are privileged with the flexibility to fight for what we believe in – and we choose to fight for: A BETTER WORLD FOR PETS. For further information about Mars Petcare, please visit www.mars.com

Categories: News

Tags: